Back
Coherus Oncology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
CHRS
Coherus Oncology, Inc.
Last Price:
$1.73
Seasonality Move:
-3.68%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHRS is experiencing slight buying pressure.
Coherus Oncology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Buy |
| 20-day SMA: | 1.7 | Buy |
| 50-day SMA: | 1.83 | Sell |
| 200-day SMA: | 1.41 | Buy |
| 8-day EMA: | 1.66 | Buy |
| 20-day EMA: | 1.33 | Buy |
| 50-day EMA: | 0.79 | Buy |
| 200-day EMA: | 0.25 | Buy |
Coherus Oncology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 51.49 | Buy |
| Chaikin Money Flow: | 155132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 1.8) | Buy |
| Bollinger Bands (100): | (1.29 - 1.91) | Buy |
Coherus Oncology, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Coherus Oncology, Inc. Stock
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.73 while CHRS 8-day simple moving average is 1.69, which is a Buy signal.
-
The stock price of CHRS is 1.73 while Coherus Oncology, Inc. 20-day SMA is 1.70, which makes it a Buy.
-
Coherus Oncology, Inc. 50-day simple moving average is 1.83 while CHRS share price is 1.73, making it a Sell technically.
-
CHRS stock price is 1.73 and Coherus Oncology, Inc. 200-day simple moving average is 1.41, creating a Buy signal.
CHRS Technical Analysis vs Fundamental Analysis
Sell
44
Coherus Oncology, Inc. (CHRS)
is a Sell
Is Coherus Oncology, Inc. a Buy or a Sell?
-
Coherus Oncology, Inc. stock is rated a SellThe current Coherus Oncology, Inc. [CHRS] share price is $1.73. The Score for CHRS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Coherus Oncology, Inc. Stock Info
Market Cap:
257.1M
Price in USD:
1.73
Share Volume:
537.2K
Coherus Oncology, Inc. 52-Week Range
52-Week High:
2.62
52-Week Low:
0.71
Sell
44
Coherus Oncology, Inc. (CHRS)
is a Sell
Coherus Oncology, Inc. Share Price Forecast
-
What is the Coherus Oncology, Inc. stock price today?The Coherus Oncology, Inc. stock price is 1.73 USD today.
-
Will CHRS stock go up or go down?Coherus Oncology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Coherus Oncology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Coherus Oncology, Inc. is overvalued.
Is Coherus Oncology, Inc. Stock a Buy?
-
Coherus Oncology, Inc. share price is 1.73 while CHRS 8-day exponential moving average is 1.66, which is a Buy signal.
-
The stock price of CHRS is 1.73 while Coherus Oncology, Inc. 20-day EMA is 1.33, which makes it a Buy.
-
Coherus Oncology, Inc. 50-day exponential moving average is 0.79 while CHRS share price is 1.73, making it a Buy technically.
-
CHRS stock price is 1.73 and Coherus Oncology, Inc. 200-day simple moving average is 0.25, creating a Buy signal.
Fundamental Analysis of Coherus Oncology, Inc.
Is Coherus Oncology, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.04 per share, an increase this year of $0.60 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Coherus Oncology, Inc.
Should I short Coherus Oncology, Inc. stock?
-
CHRS Moving Average Covergence Divergence (MACD) indicator is 0.38, suggesting Coherus Oncology, Inc. is a Buy
-
Coherus Oncology, Inc. Relative Strength Index (RSI) is 51.49, which suggest Coherus Oncology, Inc. is overbought
-
The Bollinger Bands (25) for Coherus Oncology, Inc. is (1.6 - 1.8), which suggest Coherus Oncology, Inc. is a Buy
-
The Bollinger Bands (100) for Coherus Oncology, Inc. is (1.29 - 1.91), which suggest Coherus Oncology, Inc. is a Buy
* Coherus Oncology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.